Amigo
PrivateLast Round
Series A
Mar 10, 2026
Total Funding Raised
$17.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Amigo operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in March 2026.
Amigo is a healthtech and artificial intelligence company that provides a platform for creating safe, reliable, and transparent AI agents for healthcare organizations.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Patient Engagement, Medical AI, NLP & Conversational AI, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amigo Comparables
Compare Amigo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orbita | 87% | |
| Sully.ai | 84% | |
| Hyro | 81% |
For institutional investors. Book with your work email.
Amigo Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Amigo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coho Deeptech | Seed |
| SV Angel | Seed |
| GSV Ventures | Series A, Seed |
| Optum Ventures | Series A |
| General Catalyst | Series A, Seed |
| Madrona Venture Group | Series A |
| Ride Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 49% MoM to 51.4K.
- Mar 19, 2026
Added FAM, a technology/fintech SMB, as a customer.
For institutional investors. Book with your work email.
Amigo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amigo's valuation, stock price, and market status.
Is Amigo a public or private company?
Amigo is a private company.
What is the current stock price of Amigo?
Amigo is a private company, so its shares have no public market price. Caplight tracks Amigo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amigo worth (valuation)?
Valuation information for Amigo is not publicly available.
Can I buy Amigo stock?
Amigo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amigo's last funding round?
Amigo's most recent funding round was Series A on March 10, 2026.
Who are the main investors in Amigo?
Key investors in Amigo include GSV Ventures, General Catalyst, Madrona Venture Group, GSV Ventures.
Will Amigo IPO soon?
No public IPO plans have been announced for Amigo.
How can I track Amigo secondary market activity?
Caplight tracks bids, offers, and trades in Amigo's shares on secondary markets.